Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewAZD 1480 is a potent and selective JAK2 inhibitor (IC50 < 3 nM). Exhibits >50-fold selectivity for JAK2 over JAK3. Exhibits antitumor effects and inhibits formation of lung metastases in a mouse renal cancer model. Also inhibits STAT3 signaling, tumor angiogenesis and myeloid cell migration in vivo.
AZD 1480 is also offered as part of the Tocriscreen 2.0 Max, Tocriscreen Antiviral Library and Tocriscreen Epigenetics Library. Find out more about compound libraries available from Tocris.
M. Wt | 348.77 |
Formula | C14H14ClFN8 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 935666-88-9 |
PubChem ID | 16659841 |
InChI Key | PDOQBOJDRPLBQU-QMMMGPOBSA-N |
Smiles | C[C@@H](C1=NC=C(F)C=N1)NC2=NC=C(Cl)C(NC3=NNC(C)=C3)=N2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 34.88 | 100 | |
ethanol | 34.88 | 100 |
The following data is based on the product molecular weight 348.77. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.87 mL | 14.34 mL | 28.67 mL |
5 mM | 0.57 mL | 2.87 mL | 5.73 mL |
10 mM | 0.29 mL | 1.43 mL | 2.87 mL |
50 mM | 0.06 mL | 0.29 mL | 0.57 mL |
References are publications that support the biological activity of the product.
Ioannidis S et al (2011) Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway. J.Med.Chem. 54 262 PMID: 21138246
Xin et al (2011) Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480. Cancer Res. 71 6601 PMID: 21920898
If you know of a relevant reference for AZD 1480, please let us know.
Keywords: AZD 1480, AZD 1480 supplier, AZD1480, JAK2, inhibitors, cancer, anticancers, metastasis, angiogenesis, STAT3, signaling, potent, selective, inhibits, JAK, Antiangiogenics, Kinase, 5617, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for AZD 1480 include:
John D et al (2021) Nitric Oxide Induces a Janus Kinase-1-Dependent Inflammatory Response in Primary Murine Astrocytes. ASN Neuro 13 17590914211033650 PMID: 34498493
Maarten H et al (2020) Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells. Biochem Biophys Rep 24 100832 PMID: 33102814
Do you know of a great paper that uses AZD 1480 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review AZD 1480 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image